Trial
NCT00425815
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, Los Angeles
Collaborators
University of Maryland; Washington University School of Medicine; Massachusetts General Hospital; Nathan Kline Institute for Psychiatric Research; Columbia University; Duke University; Beth Israel Deaconess Medical Center
Condition
Schizophrenia
Intervention
Org 24448
Why stopped
Study terminated at Sponsor's request.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-09